Evidence map›Paper›PMID 35048187›Full record

ArticlePflugers Archiv : European journal of physiology2022

Neuronal allodynic mechanisms of Slc7a5 (LAT1) in the spared nerve injury rodent model of neuropathic pain.

Aleyah E Goins, Kimberly Gomez, Dongzhi Ran, Mitra Afaghpour-Becklund, Rajesh Khanna, Sascha R A Alles

Open access · greenAbstract read
In one paragraph

Article in Pflugers Archiv : European journal of physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Shaping the Action Potential in Dorsal Root and Trigeminal Ganglia Neurons: Relevance to Pain Mechanisms.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. An Overview of the Mechanisms Involved in Neuralgia.Journal of inflammation research · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Aleyah E GoinsDepartment of Anesthesiology and Critical Care Medicine, University of New Mexico School of Medicine, Albuquerque, NM, 87106, USA.
Kimberly GomezComprehensive Pain and Addiction Center, The University of Arizona, Tucson, AZ, 85724, USA.ORCID 0000-0003-1867-5041
Dongzhi RanComprehensive Pain and Addiction Center, The University of Arizona, Tucson, AZ, 85724, USA.
Mitra Afaghpour-BecklundDepartment of Anesthesiology and Critical Care Medicine, University of New Mexico School of Medicine, Albuquerque, NM, 87106, USA.
Rajesh KhannaComprehensive Pain and Addiction Center, The University of Arizona, Tucson, AZ, 85724, USA. rkhanna@arizona.edu.ORCID 0000-0002-9066-2969
Sascha R A AllesDepartment of Anesthesiology and Critical Care Medicine, University of New Mexico School of Medicine, Albuquerque, NM, 87106, USA. salles@salud.unm.edu.ORCID 0000-0001-8532-8950
University of Arizona · USUniversity of New Mexico · US

Funding

CRMP2, mitochondria, and Huntington’s diseaseR01NS098772 · NINDS · INDIANA UNIVERSITY INDIANAPOLIS · PI BRUSTOVETSKY, NICKOLAY, KHANNA, RAJESH · 2017 to 2021
$2.8M
Sentrin proteases, CRMP2 deSUMOylation, and Chronic PainR01NS120663 · NINDS · UNIVERSITY OF FLORIDA · PI KHANNA, RAJESH · 2020 to 2021
$2.6M
Neuroimmune mechanisms of a humanized CCK-B receptor scFv as therapy for chronic pain patientsUG3NS123958 · NINDS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI ALLES, SASCHA R, WESTLUND-HIGH, KARIN N. · 2021 to 2022
$1.1M
NINDS NIH HHS R01 NS098772NINDS NIH HHS R01 NS120663NINDS NIH HHS UG3 NS123958
6 · The paper itself

Abstract

High-impact chronic pain is suffered by 1 in 5 patients in the USA and globally. Effective, non-addictive, non-opioid therapeutics are urgently needed for the treatment of chronic pain. Slc7a5 (Lat1), also known as system L-neutral amino acid transporter, is involved in a number of physiological processes related to inflammation. Transcriptomics studies have shown that Slc7a5 and its binding partner Slc3a2 are expressed in neurons of the dorsal root ganglia (DRG) and spinal dorsal horn, which are critical to the initiation and maintenance of nociception and pathophysiology of chronic pain. In addition, Slc7a5 is a transporter for the first-line anti-allodynic gabapentinoid drugs and binds to ion channels implicated in nociception and chronic pain including the voltage-gated sodium channel Nav1.7 and the voltage-gated potassium channels K

Indexed as

HyperalgesiaLarge Neutral Amino Acid-Transporter 1NeuralgiaAnimalsGanglia, SpinalHumansMiceNeuronsRatsRats, Sprague-DawleyRodentiaSpinal Cord Dorsal HornLarge Neutral Amino Acid-Transporter 1Slc7a5 protein, mouseSlc7a5 protein, ratChronic painElectrophysiologyNociceptorSlc7a5 (LAT1)

Identifiers

PMID35048187
PMCPMC8930528
OpenAlexW4206599259

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.